IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Date	Title
23/04/2008	Abacavir & Didanosine-Important Safety Information from GlaxoSmithKline and Bristol-Myers Squibb as approved by the IMB
16/07/2009	Abelcet (amphotericin B-lipid complex) - Important Safety Information from Cephalon as approved by the Irish Medicines Board
21/10/2009	ACERYCAL (perindopril, amlodipine) - Important Safety Information from Les Laboratoires Servier
15/03/2010	Aclasta (zoledronic acid) - Important Safety Information from Novartis as approved by the Irish Medicines Board
27/07/2007	Acomplia (rimonabant) 20mg film-coated tablet - Important Safety Information from Sanofi Aventis as approved by the Irish Medicines Board
14/07/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis as approved by the IMB
24/10/2008	Acomplia (rimonabant)-Important Safety Information from Sanofi Aventis concerning the suspension of Acomplia
03/08/2011	Actos (pioglitazone hydrochloride) and Competact (pioglitazone hydrochloride and metformin hydrochloride) - Important Safety Information from Takeda as approved by the Irish Medicines Board
27/03/2007	Actos (Pioglitazone) - Important Safety Information from Takeda as approved by the Irish Medicines Board
21/05/2012	Adenuric (febuxostat) - Important Safety Information from Menarini as approved by the Irish Medicines Board
27/02/2012	Aliskiren-containing medicinal products - Important Safety Information from Novartis Ireland as approved by the Irish Medicines Board
12/11/2010	Alupent Syrup (orciprenaline sulphate) - Important Safety Information from Boehringer Ingelheim
22/02/2010	An update on the association of natalizumab (TYSABRI) with Progressive Multifocal Leukoencephalopathy (PML) - Important Safety Information from Elan and Biogen Idec (Ireland) Limited as approved by the Irish Medicines Board
04/01/2013	Angiox (bivalirudin) - Important Safety Information from The Medicines Company as approved by the Irish Medicines Board
29/10/2007	Angiox (bivalirudin) - Important Safety informtion from The Medicines Company as approved by the Irish Medicines Board
31/01/2012	Apidra (insulin glulisine) - Important Safety Information from Sanofi-Aventis as approved by the Irish medicines Board
04/08/2006	Aptivus (tipranavir) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board
23/05/2005	Arcoxia (etoricoxib) - Important safety information from Merck Sharp & Dohme as approved by the Irish Medicines Board
30/09/2008	Arcoxia (etoricoxib)-Important Safety Information from Merck Sharp & Dohme following approval by the IMB
07/03/2007	Avandia (rosiglitazone maleate) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board